IDegLira improves time in range in a cohort of patients with type 2 diabetes: TiREX study.

ABSTRACT:

Aims

To assess the effects of IDegLira on glucometric indices deriving from intermittently scanned Continuous Glucose Monitoring (isCGM) in patients with type 2 diabetes (T2D).

Methods

Retrospective, observational, cohort, multi-center, "pre - post" study. All adults consecutively identified in the medical records who started treatment with IDegLira, and for whom an isCGM report before and after the initiation of IDegLira was available were included in the study. Time in range (TIR) represented the primary endpoint. Additional glucometric indices, insulin doses and body weight were also assessed.

Results

Overall, 87 patients were included by 5 diabetes centers [mean age 70.2 ± 11.0 years, mean duration of T2D 15.5 ± 9.6 years; BMI 29.4 ± 5.4 kg/m², baseline

SUBMITTER: Malighetti ME 

PROVIDER: S-EPMC11872972 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature